We are live on ! Find out more
TGX

THERAGENICS CORP
TGX

Delisted

TGX was delisted on the 29th of October, 2013.

Back to rankings

41 hedge funds and large institutions have $32.3M invested in THERAGENICS CORP in 2013 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 6 increasing their positions, 14 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

350% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 2

30% more capital invested

Capital invested by funds: $24.9M → $32.3M (+$7.43M)

21% more funds holding

Funds holding: 34 → 41 (+7)

57% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 14

Holders
41
Holders Change
+7
Holders Change %
+20.59%
% of All Funds
1.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
6
Reduced
14
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
LIM
Longfellow Investment Management
Massachusetts
+$3.11M
2
GLAM
Gardner Lewis Asset Management
Pennsylvania
+$1.83M
3
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
+$891K
4
LOM
Loeb Offshore Management
New York
+$839K
5
Renaissance Technologies
Renaissance Technologies
New York
+$259K

Top Sellers

Rank Fund Capital Flow
1
CC
Cannell Capital
Wyoming
-$783K
2
AG
Algert Global
California
-$186K
3
AA
Ancora Advisors
Ohio
-$149K
4
BCM
Bridgeway Capital Management
Texas
-$119K
5
BGIM
Brandywine Global Investment Management
Pennsylvania
-$66K
Name Holding Trade Value Shares
Change 		Change in
Stake
State Street
26
State Street
Massachusetts
$66K -$213 -100 -0.3%
HM
27
Harvest Management
New York
$65K – – –
U
28
UBS
Switzerland
$44K +$41.3K +19,364 +1,936%
T. Rowe Price Associates
29
T. Rowe Price Associates
Maryland
$39K – – –
Morgan Stanley
30
Morgan Stanley
New York
$38K -$49K -22,983 -57%
Citadel Advisors
31
Citadel Advisors
Florida
$33K +$32.5K +15,221 New
PNC Financial Services Group
32
PNC Financial Services Group
Pennsylvania
$22K – – –
BA
33
BlackRock Advisors
Delaware
$12K – – –
NFA
34
Nationwide Fund Advisors
Ohio
$7K – – –
Bank of America
35
Bank of America
North Carolina
$6K +$5.8K +2,720 New
FNYS
36
First New York Securities
New York
$6K +$6.82K +3,200 New
AIG
37
American International Group
New York
$4.36K – – –
MAM
38
Meeder Asset Management
Ohio
$4K – – –
TRCT
39
Tower Research Capital (TRC)
New York
$2K -$9.59K -4,500 -83%
Wells Fargo
40
Wells Fargo
California
$2K -$640 -300 -23%
AG
41
Algert Global
California
– -$186K -89,833 Closed
BGIM
42
Brandywine Global Investment Management
Pennsylvania
– -$66K -31,500 Closed
1
2

TGX Hedge Fund Activity: Q3 2013 in Review

41 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in THERAGENICS CORP (TGX) for Q3 2013, worth a combined $32.3M — up 30% from $24.9M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new TGX positions and 2 closed out — a net gain of 7 holders — while 6 added to existing stakes and 14 trimmed.

The largest buyer was Longfellow Investment Management, opening a new position worth an estimated $3.11M. The largest seller was Cannell Capital, cutting an estimated $783K.

  • 41 institutional investors held THERAGENICS CORP (TGX) as of Q3 2013, up from 34 in Q2 2013.
  • Funds reported $32.3M of THERAGENICS CORP stock for Q3 2013, up 30% quarter-over-quarter.
  • 9 funds opened new THERAGENICS CORP positions in Q3 2013 and 2 closed out, a net change of +7 holders.
  • The largest THERAGENICS CORP buyer in Q3 2013 was Longfellow Investment Management, an estimated $3.11M added.
  • The largest THERAGENICS CORP seller in Q3 2013 was Cannell Capital, an estimated $783K sold.

Based on aggregated 13F filings for Q3 2013.